This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated MYH1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-MYH1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~223.1 kDa | |
| Gel | 4–12% gradient (standard starting point) | |
| Positive control | Heart muscle (IHC candidate; verify WB) +1 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Methylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A09420 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | extracts of various cell lines, (catalog A09420) |
| Gel % | 4–12% gradient (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | Blocking buffer: 3% nonfat dry milk in TBST (catalog A09420) |
| Primary antibody | A09420 · 1:410 (catalog A09420) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Goat Anti-Rabbit IgG, 1:10000 (catalog A09420) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL (catalog A09420) |
MYH1 is predicted at 223.1 kDa; its assembly and documented modifications could affect samples, but altered Western-blot migration has not been demonstrated here.
| Band near 223.1 kDa | Consistent with full-length MYH1; confirm identity with controls. |
| Higher molecular weight band | Could reflect incomplete dissociation of a myosin complex; identity requires confirmation. |
| Weak or absent band in a myofibril-poor lysate | MYH1 is localized to myofibrillar thick filaments. |
| Multiple bands near the expected position | MYH1 has documented modification sites, but distinct migrating forms are not established. |
| Predicted full-length mass | Sets a reference of 223.1 kDa, not a measured migration position. |
| Phosphorylation sites including Thr64 and Thr69 | Modification is documented, but a visible size shift is not established. |
| Trimethyllysine at residue 130 | Modification is documented, but a visible size shift is not established. |
| Pros-methylhistidine at residue 757 | Modification is documented, but a visible size shift is not established. |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | The sample may contain little myofibrillar MYH1. | Check muscle content and analyze a myofibril-enriched fraction. |
| Band higher than expected | A myosin complex may have dissociated incompletely. | Check sample denaturation and compare with a well-denatured preparation. |
| Band lower than expected | The band may be a fragment or an unrelated protein. | Check sample integrity and confirm identity with an independent antibody. |
| Multiple bands | Fragments or antibody cross-reactivity may contribute; distinct MYH1 isoform bands are not documented here. | Compare antibody epitopes and use a positive-control muscle sample. |
| Weak or no signal | Poor recovery of MYH1 from thick filaments may reduce signal. | Check extraction and loading with a muscle positive control. |
| Fragments below expected size | MYH1 may have degraded during sample preparation. | Process samples promptly with protease inhibitors and compare fresh lysate. |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Heart muscle | cardiomyocytes | High | Protein (IHC) | HPA → |
| Skeletal muscle | myocytes | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for MYH1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A09420 is an anti-MYH1 antibody listed as reactive with human, mouse, and rat. Its Western blot image uses extracts from various cell lines at 1:410 dilution and 25 µg per lane; the caption does not identify the cell lines or species.
Which to pick: A09420 is the only listed option and has a Western blot image. Check that its listed reactivity covers your species, and use the reported 1:410 dilution as a starting point.